An ergocryptine as a lactation inhibitor.

Abstract

A double-blind trial was performed on 40 parturient women to compare the efficacy of an ergocryptine (CB 154) as a lactation inhibitor in comparision with chlorotrianisine (TACE). The two drugs were about equally effective. The drug CB 154 is unlikely to be associated with puerperal thrombo-embolism, it does not seem to be followed by rebound lactation, and it may prove particularly effective in women with a previous history of puerperal mastitis or breast engorgement.